Kobayashi M et al. |
HLA-DR matching effect in orthotopic liver transplantation under FK 506. |
1993 |
Transplant. Proc. |
pmid:7679812
|
Watanabe K et al. |
Fate of long-surviving allografts in tolerant recipients induced by fractionated lymphoid irradiation, donor bone marrow cell infusion, and FK 506 after retransplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679813
|
Valdivia LA et al. |
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. |
1993 |
Transplant. Proc. |
pmid:7679816
|
Murase N et al. |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. |
1993 |
Transplant. Proc. |
pmid:7679817
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Kahan BD |
Cyclosporine: the base for immunosuppressive therapy--present and future. |
1993 |
Transplant. Proc. |
pmid:7679819
|
Starzl TE |
FK 506 versus cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7679820
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Tzakis AG et al. |
Two-year experience with FK 506 in pediatric patients. |
1993 |
Transplant. Proc. |
pmid:7679822
|
Gibbs JF et al. |
Outcome analysis of FK 506 therapy for acute and chronic rejection. |
1993 |
Transplant. Proc. |
pmid:7679823
|
Fung J et al. |
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7680146
|
Shibata T et al. |
Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart? |
1993 |
Transplant. Proc. |
pmid:7680147
|
Todo S et al. |
Intestinal transplantation in humans under FK 506. |
1993 |
Transplant. Proc. |
pmid:7680148
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
McCauley J et al. |
FK 506 in the management of nephrotic syndrome after renal transplantation. |
1993 |
Transplant. Proc. |
pmid:7680154
|
Mañez R et al. |
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7680170
|
McCauley J |
The nephrotoxicity of FK506 as compared with cyclosporine. |
1993 |
Curr. Opin. Nephrol. Hypertens. |
pmid:7532089
|
Woan MC et al. |
Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. |
1993 |
Transplant. Proc. |
pmid:7680171
|
Rilo HR et al. |
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. |
1993 |
Transplant. Proc. |
pmid:7680172
|
Manev H et al. |
Macrolide antibiotics protect neurons in culture against the N-methyl-D-aspartate (NMDA) receptor-mediated toxicity of glutamate. |
1993 |
Brain Res. |
pmid:7504570
|
Takahara S et al. |
[Blood level monitoring of FK506 on kidney transplant recipients]. |
1993 |
Nippon Hinyokika Gakkai Zasshi |
pmid:7504758
|
Lieberman I et al. |
Synergy between tetrandrine and FK506 in prevention of diabetes in BB rats. |
1993 |
Life Sci. |
pmid:7504774
|
Müller MK et al. |
[Pathophysiologic concepts and protective possibilities in experimental pancreatic lesions]. |
1993 |
Z Gastroenterol |
pmid:7504856
|
Tanaka N et al. |
Regulation of liver regeneration by interleukin-2 and its inhibitors: cyclosporine A and FK 506. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682200
|
Panis Y and Valleur P |
[Small intestine transplantation. Experimental and clinical results]. |
1993 |
Ann Chir |
pmid:7504899
|
Bruserud O and Pawelec G |
Cyclosporine A and FK506 show similar immunosuppressive effects on long-term in vitro T-cell proliferation. |
1993 |
Int. J. Immunopharmacol. |
pmid:7682202
|
Tsai M et al. |
Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. |
1993 |
Eur. J. Immunol. |
pmid:7504992
|
Winkler M et al. |
Anaemia associated with FK 506 immunosuppression. |
1993 |
Lancet |
pmid:7682273
|
Hendrickson BA et al. |
Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1. |
1993 |
Gene |
pmid:7505249
|
Lundemose AG et al. |
Chlamydia trachomatis Mip-like protein has peptidyl-prolyl cis/trans isomerase activity that is inhibited by FK506 and rapamycin and is implicated in initiation of chlamydial infection. |
1993 |
Mol. Microbiol. |
pmid:7682281
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Deardon DJ et al. |
Small bowel tonometry: a possible technique for detecting early small bowel allograft dysfunction. |
1993 |
Transplant. Proc. |
pmid:7505502
|
Frank B et al. |
Neurotoxicity of FK 506 in liver transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7682355
|
Demetris AJ et al. |
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. |
1993 |
Transplant. Proc. |
pmid:7505503
|
Klintmalm GB et al. |
Rejection: FK 506 for rescue or maintenance. |
1993 |
Transplant. Proc. |
pmid:7682356
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Woodle ES et al. |
FK 506 rescue therapy: early conversion improves efficacy. |
1993 |
Transplant. Proc. |
pmid:7682359
|
Woodle ES et al. |
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. |
1993 |
Transplant. Proc. |
pmid:7682360
|
Fernandes JB et al. |
Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation. |
1993 |
Cell. Mol. Biol. Res. |
pmid:7507391
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
McDiarmid SV et al. |
FK506 conversion for intractable rejection of the liver allograft. |
1993 |
Transpl. Int. |
pmid:7507675
|
Akita K and Mandel TE |
Effect of FK 506 and anti-CD4 monoclonal antibody treatment on xenografts of organ-cultured fetal pig pancreas and host lymphoid populations. |
1993 |
Transplant. Proc. |
pmid:7692650
|
Tokunaga Y et al. |
Living related liver transplantation across ABO blood groups with FK506 and OKT3. |
1993 |
Transpl. Int. |
pmid:7507676
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Winkler M et al. |
Conversion from cyclosporin to FK 506 after liver transplantation. |
1993 |
Transpl. Int. |
pmid:7507677
|
David M et al. |
[Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. |
1993 |
Zentralbl Gynakol |
pmid:7692689
|
Wallemacq PE and Reding R |
FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. |
1993 |
Clin. Chem. |
pmid:7693372
|
Nakamura T et al. |
Protein phosphatase type 2B (calcineurin)-mediated, FK506-sensitive regulation of intracellular ions in yeast is an important determinant for adaptation to high salt stress conditions. |
1993 |
EMBO J. |
pmid:7693452
|
Higa A et al. |
Attenuation of epithelial injury in acute experimental colitis by immunomodulators. |
1993 |
Eur. J. Pharmacol. |
pmid:7693488
|
McCauley J et al. |
Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. |
1993 |
Nephrol. Dial. Transplant. |
pmid:7508098
|
Schmitt J et al. |
Cloning and expression of a mouse cDNA encoding p59, an immunophilin that associates with the glucocorticoid receptor. |
1993 |
Gene |
pmid:7693550
|
Nishikawa T et al. |
Kinetic analysis of molecular interconversion of immunosuppressant FK506 by high-performance liquid chromatography. |
1993 |
Pharm. Res. |
pmid:7508108
|
Shafiee A et al. |
Enzymatic synthesis and immunosuppressive activity of novel desmethylated immunomycins (ascomycins). |
1993 |
J. Antibiot. |
pmid:7693638
|
Keicho N et al. |
Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. |
1993 |
J. Antibiot. |
pmid:7693639
|
Timerman AP et al. |
The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. Dissociation and reconstitution of FKBP-12 to the calcium release channel of skeletal muscle sarcoplasmic reticulum. |
1993 |
J. Biol. Chem. |
pmid:7693682
|
Tamura K et al. |
Inhibitory effect of FK 506 on autoimmune thyroid disease in the PVG rat. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509135
|
Ochiai T et al. |
Combination of immunosuppressive drugs for organ transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509136
|
Wiederrecht G et al. |
The mechanism of action of FK-506 and cyclosporin A. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509138
|
Morikawa K et al. |
Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7509146
|
Schwaninger M et al. |
The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. |
1993 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7509460
|
Takeda Y et al. |
Stimulation of endothelin mRNA and secretion in human endothelial cells by FK 506. |
1993 |
J. Cardiovasc. Pharmacol. |
pmid:7509973
|
Jachez B et al. |
Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. |
1993 |
Anticancer Drugs |
pmid:7683935
|
Shapiro R et al. |
FK 506 interaction with danazol. |
1993 |
Lancet |
pmid:7684106
|
Becker JW et al. |
FK-506-binding protein: three-dimensional structure of the complex with the antagonist L-685,818. |
1993 |
J. Biol. Chem. |
pmid:7684380
|
Dickey JB et al. |
Periocular FK-506 delays allograft rejection in rat penetrating keratoplasty. |
1993 |
Cornea |
pmid:7684663
|
Francavilla A et al. |
Hepatic regeneration and growth factors. |
1993 |
J Surg Oncol Suppl |
pmid:7684910
|
Connelly PR et al. |
Probing hydration contributions to the thermodynamics of ligand binding by proteins. Enthalpy and heat capacity changes of tacrolimus and rapamycin binding to FK506 binding protein in D2O and H2O. |
1993 |
Biochemistry |
pmid:7684925
|
Wallemacq PE et al. |
Improvement and assessment of enzyme-linked immunosorbent assay to detect low FK506 concentrations in plasma or whole blood within 6 hours. |
1993 |
Clin. Chem. |
pmid:7684956
|
Mochizuki M et al. |
A clinical trial of FK506 in refractory uveitis. |
1993 |
Am. J. Ophthalmol. |
pmid:7685147
|
Hibbins M et al. |
Inhibition of PHA induced mononuclear cell proliferation by FK506 in combination with cyclosporine, methylprednisolone, 6-mercaptopurine and mycophenolic acid. |
1993 |
Transpl. Immunol. |
pmid:7521736
|
Thomson AW et al. |
Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. |
1993 |
Transpl. Immunol. |
pmid:7521738
|
Matsuura T et al. |
Organ-specific unresponsiveness induced by intrathymic injection of donor bone marrow cells and a short course of immunosuppression in the rat heart transplantation model. |
1993 |
Transpl. Immunol. |
pmid:7521742
|
Langer A et al. |
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. |
1993 |
Am. J. Pathol. |
pmid:7686346
|
Fujisawa T et al. |
Dose study of the immunosuppression of FK 506 in canine lung allo-transplantation. |
1993 |
Surg. Today |
pmid:7686416
|
Ueno M et al. |
[Immunosuppressive effect in combination therapy of cyclosporine A, FK506 and 15-deoxyspergualin on a pancreatic islet xenotransplantation]. |
1993 |
Nihon Geka Gakkai Zasshi |
pmid:7686615
|
Thomson AW et al. |
FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. |
1993 |
Springer Semin. Immunopathol. |
pmid:7686690
|
Koga T et al. |
Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. |
1993 |
Chest |
pmid:7686837
|
Renoir JM et al. |
Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor. |
1993 |
C. R. Acad. Sci. III, Sci. Vie |
pmid:7522118
|
Nishi M et al. |
Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. |
1993 |
Invest. Ophthalmol. Vis. Sci. |
pmid:7686893
|
Nishizawa S et al. |
Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. |
1993 |
Neurosurgery |
pmid:7687044
|
Warty V et al. |
FK506 measurement: comparison of different analytical methods. |
1993 |
Ther Drug Monit |
pmid:7687389
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Odocha O et al. |
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689268
|
Odocha O et al. |
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7689269
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
McMaster P and Buist L |
FK 506 in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689275
|
Jost U et al. |
FK 506 treatment of intractable rejection after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689276
|
Winkler M et al. |
Plasma level-guided low-dose FK 506 therapy in patients with early liver dysfunction after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7689277
|
Viebahn R et al. |
Simulation of hypoxic and preservation injury in human hepatocyte cultures: influence of FK 506 and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7689278
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Cetinkale O et al. |
The use of FK506 and skin allografting for the treatment of severe burns in an animal model. |
1993 |
Br J Plast Surg |
pmid:7690295
|
Hacker J and Fischer G |
Immunophilins: structure-function relationship and possible role in microbial pathogenicity. |
1993 |
Mol. Microbiol. |
pmid:7526121
|
Hom JT and Estridge T |
FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophils. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690315
|
Olivera DL et al. |
Divergent effects of rapamycin on mouse and rat cells following mitogenic stimulation. |
1993 |
Clin. Immunol. Immunopathol. |
pmid:7690317
|
Whitington PF et al. |
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. |
1993 |
Lancet |
pmid:7690444
|
Takahashi H and Iizuka H |
Neither cyclosporin A nor FK506 affects adenylate cyclase responses of fetal rat keratinizing epidermal cells (FRSK cells) at concentrations that inhibit thymidine incorporation. |
1993 |
J. Dermatol. Sci. |
pmid:7511000
|
Lee KK et al. |
Successful treatment of ongoing intestinal allograft rejection permits recovery of graft structure and function. |
1993 |
Am. J. Surg. |
pmid:7678188
|